Company Profile

Novonesis (Novozymes) B (OTC: NVZMY)
2:03 PM UTC, 05/23/24
Last: $61.57 Change: -1.37 %Change: -2.18% Volume: 369
Detailed Quote
Open: $ 61.97   Volume: 369
High: $ 61.97   Yield(%) 1.51
Low: $ 61.57   P/E Ratio (ttm): 39.92
Dividend ($): 0.19   Market Cap ($): 25.98B
EPS ($) 1.58   Shares Out: 410.87M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 13.73
% Price Change (last 13 weeks): 13.20
% Price Change (last 26 weeks): 20.22
% Price Change (last 52 weeks): 23.73
% Price Change (year to date): 14.98
Management Effectiveness
Return on Equity (%): 21.63
Return on Assets (%): 10.63
Return on Invested Capital (%): 19.86
Profitability
Gross Profit Margin (%): 52.03
Net Profit Margin (%): 16.89
Operating Profit Margin (%): 24.96
Price & Volume
50-day Moving Average: $58.16
200-day Moving Average: $51.27
Avg. Daily Vol. (last 50 days): 9,473
Avg. Daily Vol. (last 200 days): 26,220
52-wk high: $63.89
52-wk low: $38.75
Bid: $n/a
Ask: $n/a
Company Information
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
Novonesis (Novozymes) B
Biologiens Vej 2
Lyngby ND 2800

Phone: n/a
Fax: n/a
http://www.novonesis.com
Per Share Data
Earnings (1year) ($): 1.58
Annual Dividend ($): 0.57
Current P/E Ratio (ttm): 39.92
Book Value ($): 7.47
Cash Flow ($): 2.86
Valuation Ratios
Price/Earnings (x): 39.92
Price/Sales (x): 5.88
Price/Book (x): 7.36
Price/Cash Flow (x): 25.36
Financial Strength
Quick Ratio (x): 0.80
Current Ratio (x): 1.30
LT Debt/Equity (x): 32.63
Total Debt/Equity (x): 55.67



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.